Evidence map›Paper›PMID 41054892›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

Stiff and Fracture-Resistant Ion Gels Enabled by Synergetic Physical Entanglement and Hydrogen Bonding.

Ryota Tamate, Yuji Kamiyama, Ken Kojio

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ryota TamateResearch Center for Macromolecules & Biomaterials, National Institute for Materials Science, 1-2-1 Sengen, Tsukuba, 305-0047, Japan.ORCID https://orcid.org/0000-0002-1704-1058
Yuji KamiyamaResearch Center for Macromolecules & Biomaterials, National Institute for Materials Science, 1-2-1 Sengen, Tsukuba, 305-0047, Japan.
Ken KojioPRESTO, JST, 7 Gobancho, Chiyoda-ku, Tokyo, 102-0076, Japan.

Funding

Japan Science and Technology Agency JPMJGX23S3Japan Society for the Promotion of Science 23K26409Precursory Research for Embryonic Science and Technology JPMJPR2196
6 · The paper itself

Abstract

In this study, ion gels are developed that simultaneously exhibit exceptional stiffness and fracture resistance through the synergistic effects of physical entanglements and hydrogen bonding between polymer chains within an ionic liquid matrix. Through radical copolymerization conducted in an ionic liquid under extremely low initiator concentrations, ultrahigh molecular weight polymers in situ with nearly complete monomer conversion are successfully synthesized. This strategy enabled the one-pot synthesis of physically crosslinked polymer gels composed of abundant entanglements and hydrogen bonds between polymer chains. Notably, it is demonstrated that the synergy between physical entanglements arising from ultrahigh molecular weight polymer chains and noncovalent hydrogen bonding enables the simultaneous enhancement of mechanical properties that typically exhibit trade-off relationships, such as stiffness, toughness, and fracture resistance. Consequently, the synthesized ion gels exhibited outstanding mechanical performances, ranking among the best previously reported tough polymer gels, while maintaining a favorable balance between ionic conductivity and mechanical strength. These findings underscore the broader significance of the approach, indicating that the integration of physical entanglements and reversible interactions offers a generalized pathway to mechanically robust materials across various polymer systems.

Indexed as

entanglementsfracture resistancehydrogen bondsion gelsultrahigh molecular weight polymers

Identifiers

PMID41054892
PMCPMC12674104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.